Opus Genetics names Andrew Murphy chief scientific officer
IRD•Opus Genetics appointed Andrew Murphy chief scientific officer and Jamie Lynne Hart executive director, executive operations.
1. Leadership appointments
Opus Genetics appointed Andrew Murphy chief scientific officer. Murphy previously served as senior vice president of research and early development at Kriya Therapeutics, where he led AAV vector research. The company also appointed Jamie Lynne Hart executive director, executive operations; she previously served as chief of staff to the CEO at Apellis Pharmaceuticals, now Biogen.
